In the News

Mark Mansour Discusses FDA Nominee in Law360

April 13, 2021

Mark Mansour, Washington, D.C.-based Member in Dykema’s Health Care practice group, was quoted in the Law360 article, “Speculation Abounds As Biden Is Slow To Nominate FDA Head.”

In the article, Mansour said he believes staff morale at the FDA will improve going forward. He also said the delay in picking a nominee to head the agency “suggests that they’re still thinking about it.”

To read the entire article, click here.